CN101199819B - 一种治疗帕金森综合症的中药组合物 - Google Patents
一种治疗帕金森综合症的中药组合物 Download PDFInfo
- Publication number
- CN101199819B CN101199819B CN2007101142565A CN200710114256A CN101199819B CN 101199819 B CN101199819 B CN 101199819B CN 2007101142565 A CN2007101142565 A CN 2007101142565A CN 200710114256 A CN200710114256 A CN 200710114256A CN 101199819 B CN101199819 B CN 101199819B
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- gram
- blood
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010034010 Parkinsonism Diseases 0.000 title claims abstract description 21
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000027089 Parkinsonian disease Diseases 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 241000489492 Arisaema Species 0.000 claims abstract description 10
- 210000000941 bile Anatomy 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims description 12
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241000237636 Pheretima Species 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 208000026435 phlegm Diseases 0.000 abstract description 10
- 208000011580 syndromic disease Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000012535 impurity Substances 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241000208966 Polygala Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 9
- 206010044565 Tremor Diseases 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000001259 mesencephalon Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical group C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000028752 abnormal posture Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229960001032 trihexyphenidyl Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗帕金森综合症的中药组合物，属中药领域。该种治疗帕金森综合症的中药组合物，由女贞子10-20克，丹参5-15克，天麻5-15克，丹皮5-15克，当归5-15克，地龙10-20克，党参10-20克，熟地10-20克，胆南星8-15克、郁金10-20克、远志5-15克配制而成。先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。本发明能够起到化痰除湿，行气活血的作用。且原料来源广，廉价易得，而又无毒副作用。
Description
技术领域
本发明涉及一种治疗帕金森综合症的中药组合物，属中药领域。
背景技术
帕金森病是一种中枢神经系统变性疾病，主要是因位于中脑部位″黑质″中的细胞发生病理性改变后，多巴胺的合成减少，抑制乙酰胆碱的功能降低，则乙酰胆碱的兴奋作用相对增强。两者失衡的结果便出现了“震颤麻痹”。帕金森综合症以动迟缓、肌肉强直、静止性震颤和姿势异常″四主征为临床特点。
西医治疗帕金森综合症的药物负作用比较大，病人在刚吃西药时感觉似有好转，结果病情在不知不觉中慢慢加重，西药量和品种在不断增加，病人在不断加大西药的品种和药量的麻痹下，不仅不能最终治愈震颤综合征，还会麻痹、麻醉患者的神经。使患者的神经在麻痹、麻醉下患者的各部经络日渐阻滞，各部器管不断萎缩和褪化。
发明内容
本发明的目的在于克服现有治疗的不足，而提供一种治疗帕金森综合症的中药组合物。针对帕金森综合症辨证施治，有显著疗效。
本发明解决技术问题所采取的技术方案是：
该种治疗帕金森综合症的中药组合物，其特征在于，制成药物有效成分的原料药按下述重量为：女贞子10-20克，丹参5-15克，天麻5-15克，丹皮(牡丹皮)5-15克，当归5-15克，地龙10-20克，党参10-20克，熟地(熟地黄)10-20克，胆南星8-15克、郁金10-20克、远志5-15克。
本发明进一步的技术方案是：该种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子15克，丹参10克，天麻15克，丹皮(牡丹皮)10克，当归10克，地龙10克，党参10克，熟地(熟地黄)10克，胆南星10克、郁金15克，远志10克。
配制及服用方法：先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。
药理作用：
女贞子：苦甘、平。入肝、肾经。补肝肾，强腰膝。治阴虚内热，头晕，目花，耳鸣，腰膝酸软，须发早白。滋补肝肾，明目乌发。用于眩晕耳鸣，腰膝酸软、须发早白、目暗不明。
丹参：苦，微寒；归心、肝经。活血化淤，凉血宁心。本品降而行血，善入血分，能通经脉、化淤滞、清心火、凉血热，安神志、除悸烦，常用于胸痹心痛，月经部调、疮疡肿痛，失眠及淤血肿痛等症。
天麻：味辛，温。入肝经。息风，定惊。治眩晕眼黑，头风头痛，肢体麻木，半身不遂。
丹皮(牡丹皮)：清热，凉血，和血，消瘀。治热入血分，发斑，惊痫，吐、衄、便血，骨蒸劳热，经闭，癥瘕，痈疡，扑损。
当归：甘辛，温。入心、肝、脾经。补血和血，调经止痛，润燥滑肠。治月经不调，经闭腹痛，癥瘕结聚，崩漏；血虚头痛，眩晕，痿痹；肠燥便难，赤痢后重；痈疽疮窃，跌扑损伤。
地龙：清热，平肝，止喘，通络。治高热狂躁，惊风抽搐，风热头痛，目赤，中风半身不遂，喘息，喉痹，关节疼痛，齿衄，小便不通，瘰疬。
党参：甘，平。入手、足太阴经气分。补中益气，生津，养血。用于中气不足的体虚倦怠，脾胃虚弱，气血两亏，治体倦无力，肺气亏虚。治食少，口渴，久泻，脱肛。及气血双亏的面色萎黄，头晕心悸等。
熟地(熟地黄)：既善补血滋阴，又能补精益髓，主治一切血虚阴亏精少之症。主要功能养血滋阴、补精益髓，用于血虚萎黄、眩晕、心悸.
胆南星：清火化痰，镇惊定痼。治中风痰迷，惊风癫痫，痰火喘嗽，头风眩晕。
郁金：辛苦，凉。入心、肺、肝经。行气解郁，凉血破瘀，治胸腹胁肋诸痛，失心癫狂，热病神昏。吐血，黄疸。
远志：安神益智，祛痰，解郁。治惊悸，健忘，梦遗，失眠，咳嗽多痰，痈疽疮肿。
现代医学认为：帕金森病是一种中枢神经系统变性疾病，主要是因位于中脑部位″黑质″中的细胞发生病理性改变。中医认为帕金森病的病因病机乃筋脉失养，风气内动所致。本病又多见于中老年人，或负重劳伤、气血运行失和、经络流行失畅者。发病多因肝阴不足、肝不养筋、虚实错杂逐渐累及或同时兼及肝脾肾诸脏，病情由轻转重，终致气血两虚，阴阳俱伤，因此躯干活动不能自如，身体抖动，四肢颤动等症状。针对本病的病因病机，治疗上应从发病者为老人、虚人这一特点着眼，以调和气血为主，益气健脾，平肝息风，清火化痰，兼以滋肾养脑，散瘀通络。本方以当归调和气血；丹参可补血和血；党参益气健脾；女贞子、天麻补肝肾；五味子、远志清火化痰，镇惊定痼；地龙、丹皮、郁金补精益髓，行气解郁，凉血破瘀。诸药配伍，共奏平肝、熄风、化痰除湿，行气活血之功效。
本发明将上述药物组合后，其药效具有协同作用，具有消炎软坚、散热除湿、通络止痛的功效。该种治疗帕金森综合症的中药组合物，在治疗帕金森综合症方面具有见效快，疗程短、治疗方法简单、费用低、对身体无任何副作用、不会对患者的健康有任何不利影响等优点。
典型病例
例1：陈某，女，66岁，广东人。三年前患者出现震颤症状，先以上肢为主，后逐渐发展到下肢，诊断为帕金森氏综合症，用药物可暂时控制症状。随着病情的不断发展，头部也不停的颤抖，药物的作用效果越来越差。经服用本发明药物治疗两个疗程后，头晃，手抖现象减轻，继续服药两个疗程痊愈。至今停药两年，未见复发。
例2：张宏，女，安徽人，61岁。两年前突然感觉头痛、眩晕、肢体僵硬震颤，诊断为帕金森综合症。长期服西药治疗无显效。经服用本发明药物治疗两个疗程后，患者精神好了，手臂、躯体震颤抖动均略减轻，情绪稳定，治疗初见成效。继续服药两个疗程，病人恢复良好，肢体运动灵活，头晃，手抖现象很少出现，至今停药一年未见复发。
例3，张某，男，68岁，山东济南人。患者2003年发病，头部不自主晃动，全身震颤，不能自主，在本地医院诊断为“帕金森氏病”。服用左旋陈美多巴、安坦等药，病情却逐步加重，服用本发明药方治疗一个疗程，患者症状当即缓解，肢体震颤、僵硬症状消失。继续服药两个疗程，病人恢复良好，肢体运动灵活。停药已一年有余，症状没有反弹，生活能够自更，基本恢复健康。
具体实施方式
实施例一：该种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子15克，丹参10克，天麻15克，丹皮(牡丹皮)10克，当归10克，地龙10克，党参10克，熟地(熟地黄)10克，胆南星10克、郁金15克，远志10克。
配制及服用方法：先将各原料药的杂质去除，纳诸药于砂锅中加水500毫升，煎煮半小时，一日一剂，分两次服用。
实施例二：该种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子10克，丹参10克，天麻10克，丹皮(牡丹皮)10克，当归10克，地龙10克，党参10克，熟地(熟地黄)15克，胆南星15克、郁金15克，远志10克。
配制及服用方法：同实施例一。
实施例三：该种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子15克，丹参15克，天麻15克，丹皮(牡丹皮)15克，当归10克，地龙10克，党参10克，熟地(熟地黄)10克，胆南星10克、郁金15克，远志10克。
配制及服用方法：同实施例一。
实施例四：该种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子10克，丹参10克，天麻15克，丹皮(牡丹皮)15克，当归10克，地龙10克，党参10克，熟地(熟地黄)10克，胆南星10克、郁金15克，远志15克。
配制及服用方法：同实施例一。
Claims (2)
1.一种治疗帕金森综合症的中药组合物，其特征在于，制成药物有效成分的原料药按下述重量为：女贞子10-20克，丹参5-15克，天麻5-15克，牡丹皮5-15克，当归5-15克，地龙10-20克，党参10-20克，熟地黄10-20克，胆南星8-15克、郁金10-20克、远志5-15克。
2.根据权利要求1所述的一种治疗帕金森综合症的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：女贞子15克，丹参10克，天麻15克，牡丹皮10克，当归10克，地龙10克，党参10克，熟地黄10克，胆南星10克、郁金15克，远志10克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101142565A CN101199819B (zh) | 2007-12-19 | 2007-12-19 | 一种治疗帕金森综合症的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101142565A CN101199819B (zh) | 2007-12-19 | 2007-12-19 | 一种治疗帕金森综合症的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199819A CN101199819A (zh) | 2008-06-18 |
| CN101199819B true CN101199819B (zh) | 2010-08-11 |
Family
ID=39515303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101142565A Expired - Fee Related CN101199819B (zh) | 2007-12-19 | 2007-12-19 | 一种治疗帕金森综合症的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199819B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600371B (zh) * | 2012-03-12 | 2014-01-22 | 上海交通大学医学院附属新华医院 | 一种预防帕金森病的中药组合物及其用途 |
| CN104147460A (zh) * | 2014-09-02 | 2014-11-19 | 杭州金培科技有限公司 | 一种治疗帕金森病的中药制剂及其制备方法 |
| CN104547897A (zh) * | 2014-12-09 | 2015-04-29 | 张祺 | 一种治疗帕金森病的中药组合物 |
| CN104800606A (zh) * | 2015-04-29 | 2015-07-29 | 赵汝君 | 一种治疗帕金森氏综合症的中药组合物 |
| CN110279824B (zh) * | 2019-05-22 | 2021-07-27 | 曹子成 | 一种用于治疗帕金森病的中药组合物及其应用 |
| CN111281927A (zh) * | 2020-04-17 | 2020-06-16 | 山西中医药大学 | 用于治疗帕金森氏病的中药组合物及其制备方法和用途 |
| CN111407853B (zh) * | 2020-06-04 | 2021-07-30 | 孟胜喜 | 治疗帕金森病的中药组合物及其制备方法 |
| CN115429863B (zh) * | 2022-09-01 | 2023-10-13 | 河南大学第一附属医院 | 一种治疗帕金森相关的非运动症状的中药组合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840128A (zh) * | 2005-04-01 | 2006-10-04 | 包德圻 | 一种治疗心血管疾病的药物 |
-
2007
- 2007-12-19 CN CN2007101142565A patent/CN101199819B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840128A (zh) * | 2005-04-01 | 2006-10-04 | 包德圻 | 一种治疗心血管疾病的药物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199819A (zh) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101199819B (zh) | 一种治疗帕金森综合症的中药组合物 | |
| CN1857666A (zh) | 一种治疗老年期痴呆的中药制剂 | |
| CN104069339B (zh) | 一种治疗重症肌无力的中药组合物及其制备方法 | |
| CN102935145B (zh) | 一种治疗骨质疏松的中药制剂 | |
| CN104042909A (zh) | 一种治疗糖尿病的药物 | |
| CN104689226A (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
| CN101926904B (zh) | 治疗风湿痹痛、骨关节疾病的药酒 | |
| CN101703686B (zh) | 一种治疗糖尿病的中药组合物 | |
| CN101112538A (zh) | 治疗糖尿病性高血压的中药制剂 | |
| CN101036706B (zh) | 活血化淤舒筋通络祛风湿酒 | |
| CN103251878B (zh) | 一种抗疲劳的中药组合物 | |
| CN104800606A (zh) | 一种治疗帕金森氏综合症的中药组合物 | |
| CN104547897A (zh) | 一种治疗帕金森病的中药组合物 | |
| CN103735907A (zh) | 治疗面神经炎的中药 | |
| CN103110911B (zh) | 一种治疗冠心病的中药组合物 | |
| CN103405637B (zh) | 一种治疗神经官能症的药物及其制备方法 | |
| CN101049371A (zh) | 治疗无精子性不育症的中药及其制备方法 | |
| CN101095938A (zh) | 治疗糖尿病性肌肉萎缩的一种中药 | |
| CN102091316A (zh) | 一种治疗类风湿关节炎的中药 | |
| CN101703678A (zh) | 一种治疗类风湿性关节炎的药物 | |
| CN101095901A (zh) | 治疗肾病综合征的一种中药组合 | |
| CN106214831A (zh) | 一种治疗白癜风的内服中药丸及其制备方法 | |
| CN106266711A (zh) | 一种治疗耳聋耳鸣的内服药物及其制备方法 | |
| CN105902644A (zh) | 治疗颈椎病的中药组合物及其制备方法 | |
| CN105878738A (zh) | 一种治疗气血不足证的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU TAIMING Free format text: FORMER OWNER: YU DIANAN Effective date: 20100607 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Taiming Inventor after: Yu Dianan Inventor before: Yu Dianan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 265700 NO.2085, HAIGANG ROAD, LONGKOU CITY, YANTAI CITY, SHANDONG PROVINCE TO: 252600 SHANDONG PROVINCE LINQING CITY PEOPLE S HOSPITAL TRADITIONAL CHINESE MEDICINE DEPARTMENT Free format text: CORRECT: INVENTOR; FROM: YU DIANAN TO: LIU TAIMING YU DIANAN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20100607 Address after: 252600 Department of traditional Chinese medicine, Linqing people's Hospital, Shandong Province, China Applicant after: Liu Taiming Address before: 265700 No. 2085 seaport Road, Yantai, Shandong, Longkou City Applicant before: Yu Dianan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100811 Termination date: 20101219 |